Patent Assignment
Reel/Frame 061977/0919
Security Agreement
Recorded: 2022-11-22
Pages: 14
Assignor
BIODESIX, INC.
Executed: 2022-11-21
Assignee
PERCEPTIVE CREDIT HOLDINGS IV, LP
51 ASTOR PLACE 10TH FLOOR, C/O PERCEPTIVE ADVISORS LLC, NEW YORK, NEW YORK, 10003
Covered Properties
(72)
Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease
Selection of Colorectal Cancer Patients for Treatment with Drugs Targeting Egfr Pathway
Selection of Head and Neck Cancer Patients for Treatment with Drugs Targeting Egfr Pathway
Selection of Non-Small-Cell Lung Cancer Patients for Treatment with Monoclonal Antibody Drugs Targeting Egfr Pathway
Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease
Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease
Method and System for Determining Whether a Drug Will Be Effective on a Patient with a Disease
Method and system for determining whether a drug will be effective on a patient with a disease
Method for Reliable Classification of Samples in Clinical Diagnostics Using an Improved Method of Classification
Monitoring Treatment of Cancer Patients with Drugs Targeting Egfr Pathway Using Mass Spectrometry of Patient Samples
Monitoring Treatment of Colorectal Cancer Patients with Drugs Targeting Egfr Pathway Using Mass Spectrometry of Patient Samples
Monitoring Treatment of Head and Neck Cancer Patients with Drugs Egfr Pathway Using Mass Spectrometry of Patient Samples
Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
Monitoring treatment of Head and Neck cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
A Method for Predicting Breast Cancer Patient Response to Endocrine Therapy
A Method for Predicting Breast Cancer Patient Response to Combination Therapy
Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof
Deep MALDI TOF Mass Spectrometry of Complex Biological Samples, e.g., Serum, and Uses Thereof
Mass-Spectral Method for Selection, and De-Selection, of Cancer Patients for Treatment with Immune Response Generating Therapies
Mass-Spectral Method for Selection, and De-selection, of Cancer Patients for Treatment with Immune Response Generating Therapies
Method and System for Validation of Mass Spectrometer Machine Performance
Patent:
8,467,988 →
Application:
13/733,018 →
Classification Generation Method Using Combination of Mini-Classifiers with Regularization and Uses Thereof
Treatment selection for lung cancer patients using mass spectrum of blood-based sample
Predictive Test for Aggressiveness or Indolence of Prostate Cancer from Mass Spectrometry of Blood-Based Sample
Predictive Test for Aggressiveness or Indolence of Prostate Cancer from Mass Spectrometry of Blood-Based Sample
Method of predicting development and severity of graft-versus-host disease
Patent:
9,563,744 →
Application:
14/949,229 →
Early detection of hepatocellular carcinoma in high risk populations using MALDI-TOF Mass Spectrometry
Early Detection of Hepatocellular Carcinoma in High Risk Populations Using Maldi-Tof Mass Spectrometry
Predictive Test for Prognosis of Myelodysplastic Syndrome Patients Using Mass Spectrometry of Blood-Based Sample
Patent:
11,594,403 →
Application:
15/899,866 →
Bagged Filtering Method for Selection and Deselection of Features for Classification
Predictive Test for Patient Benefit from Antibody Drug Blocking Ligand Activation of the T-Cell Programmed Cell Death 1 (PD-1) Checkpoint Protein and Classifier Development Methods
Predictive Test for Patient Benefit from Antibody Drug Blocking Ligand Activation of the T-Cell Programmed Cell Death 1 (Pd-1) Checkpoint Protein and Classifier Development Methods
Predictive Test for Melanoma Patient Benefit from Interleukin-2 (IL2) Therapy
Classifier Generation Methods and Predictive Test for Ovarian Cancer Patient Prognosis Under Platinum Chemotherapy
Method for Identification of Cancer Patients with Durable Benefit from Immunotherapy in Overall Poor Prognosis Subgroups
Method for Identification of Cancer Patients with Durable Benefit from Immunotherapy in Overall Poor Prognosis Subgroups
Application:
17/495,213 →
Publication:
US 2022/0026416
Diagnostic Test Stystem for Specific, Sensitive and Reproducible Detection of Circulating Nucleic Acids in Whole Blood
Systems and Methods for Determining the Beneficial Administration of Tumor Infiltrating Lymphocytes, and Methods of Use Thereof and Beneficial Administration of Tumor Infiltrating Lymphocytes, and Methods of Use Thereof
Application:
16/772,135 →
Publication:
US 2021/0369775
Apparatus and Method for Identification of Primary Immune Resistance in Cancer Patients
Diagnostic Lung Cancer Panel and Methods for Its Use
Alzheimer's Disease Diagnostic Panels and Methods for Their Use
Application:
15/685,535 →
Publication:
US 2018/0003724
Selected Reaction Monitoring Assays
Selected Reaction Monitoring Assays
Compositions, Methods and Kits for Diagnosis of Lung Cancer
Compositions, Methods and Kits for Diagnosis of Lung Cancer
Compositions, Methods and Kits for Diagnosis of Lung Cancer
Compositions, Methods and Kits for Diagnosis of Lung Cancer
Compositions, Methods and Kits for Diagnosis of Lung Cancer
Compositions, Methods and Kits for Diagnosis of Lung Cancer
Srm Methods in Alzheimer's Disease and Neurological Disease Assays
Compositions, Methods and Kits for Diagnosis of Lung Cancer
Compositions, Methods and Kits for Diagnosis of Lung Cancer
Integrated Quantification Method for Protein Measurements in Clinical Proteomics
Compositions, Methods and Kits for Diagnosis of Lung Cancer
Compositions, Methods and Kits for Diagnosis of Lung Cancer
Application:
17/069,666 →
Publication:
US 2021/0285950
Methods for identifying and using organ-specific proteins in blood
Patent:
9,002,652 →
Application:
11/342,366 →
Methods for Identifying and Using Organ-Specific Proteins in Blood
Methods for Identifying and Monitoring Drug Side Effects
Methods for Identifying and Monitoring Drug Side Effects
Organ-Specific Proteins and Methods of Their Use
Predictive Test for Identification of Early Stage Nsclc Stage Patients at High Risk of Recurrence After Surgery
Application:
17/430,998 →
Publication:
US 2022/0341939
Blood Sample Separation Devices and Methods
Patent:
10,422,729 →
Application:
16/296,918 →
Antibodies Targeting Pulmonary Nodule Specific Biomarkers and Uses Thereof
Patent:
11,542,340 →
Application:
17/514,737 →
Calibrator for Immunoassays
Application:
15/274,012 →
Publication:
US 2017/0074884
Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings
Interpretation of Machine Learning Classifications in Clinical Diagnostics Using Shapley Values and Uses Thereof
Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings
SARS CoV-2 INFECTIVITY DETERMINATION ASSAY
Application:
63/150,050 →
Sensitive and Accurate Feature Values from Deep Maldi Spectra
Application:
63/301,825 →
Sensitive and Accurate Feature Values from Deep Maldi Spectra
Application:
63/304,107 →
Calibrator for Immunoassays
Application:
16/952,473 →
Publication:
US 2021/0318320
Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 16, 2007
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC., A DELAWARE CORPORATION
Reel/Frame 019021/0827 →
Assignment of Assignor's Interest
Aug 12, 2008
From: TSYPIN, MAXIM; ROEDER, HEINRICH
To: BIODESIX, INC.
Reel/Frame 021388/0135 →
Assignment of Assignor's Interest
Mar 2, 2009
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 022349/0058 →
Assignment of Assignor's Interest
Mar 2, 2009
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 022348/0989 →
Assignment of Assignor's Interest
Mar 2, 2009
From: ROEDER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 022348/0985 →
Assignment of Assignor's Interest
Sep 28, 2009
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 023301/0428 →
Assignment of Assignor's Interest
Nov 9, 2009
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX, INC.
Reel/Frame 023509/0816 →
Assignment of Assignor's Interest
Feb 16, 2012
From: RODER, JOANNA; GRIGORIEVA, JULIA; RODER, HEINRICH
To: BIODESIX, INC.
Reel/Frame 027824/0265 →
Assignment of Assignor's Interest
Jan 16, 2013
From: GRIGORIEVA, JULIA; RODER, HEINRICH; RODER, JOANNA
To: BIODESIX, INC.
Reel/Frame 029637/0246 →
Assignment of Assignor's Interest
Mar 22, 2013
From: RODER, HEINRICH; ASMELLASH, SENAIT; ALLEN, JENNA; TSYPIN, MAXIM
To: BIODESIX, INC.
Reel/Frame 030069/0019 →
Short-Form Patent Security Agreement
Dec 3, 2013
From: BIODESIX, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031751/0694 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044815/0024 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044818/0967 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044817/0564 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044813/0947 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044817/0347 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044816/0809 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044815/0155 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044818/0799 →
Assignment of Assignor's Interest
Feb 2, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044817/0429 →
Assignment of Assignor's Interest
Feb 5, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044831/0054 →
Assignment of Assignor's Interest
Feb 5, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044831/0038 →
Assignment of Assignor's Interest
Feb 5, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044831/0024 →
Assignment of Assignor's Interest
Feb 5, 2018
From: RODER, HEINRICH; TSYPIN, MAXIM; GRIGORIEVA, JULIA
To: BIODESIX INC.
Reel/Frame 044831/0010 →
Security Interest
Feb 23, 2018
From: BIODESIX, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 045022/0976 →